We generate and disseminate cutting-edge, applied knowledge on explicit priority setting in health and drug prices intervention strategies in order to promote evidence-based decision making on what to finance in health with public resources and how much pay for it. In this section you will find valuable information on Health Technology Assessment (HTA), Health Benefit Plans (HBP), pharmaceutical policy, drugs and medical devices regulation, catastrophic funds, and horizon scanning, among others.
In Chile, Ricarte Soto Law defines a financial protection system for high-cost health technologies through a process of prioritization and evaluation of health technologies (ETESA).This webinar aims to evaluatethe ETESA processin terms of its technical content and analyze this experience to replicate in other countries.
The Covid-19 pandemic showed us the need to build resilience in health systems; and that addressing diseases in other countries can prevent their spread around the world.
In December 2021, the Criteria Network led a workshop that brought together renowned regional and international experts with the aim of discussing strategies to mitigate the effect of the current fiscal austerity that region is going through at this moment by adopting measures such as explicit priority setting,